Latest Articles
Black Health Matters: Ep. 3 Pt. I – Women’s Health Uncovered | Endometriosis & Fibroids in Partnership with Cedars-Sinai - Los Angeles Sentinel
Black Health Matters: Ep. 3 Pt. I – Women’s Health Uncovered | Endometriosis & Fibroids in Partnership with Cedars-Sinai Los Angeles Sentinel
Published: Aug. 8, 2025, 1:09 a.m.
“We must reject the normalization of female pain”: Lupita Nyong’o teams up with lawmakers after sharing her fibroids journey on social media - The Daily Dot
“We must reject the normalization of female pain”: Lupita Nyong’o teams up with lawmakers after sharing her fibroids journey on social media The Daily Dot
Published: July 21, 2025, 6 p.m.
Not Just Hormones: How Blood Pressure, Vitamin D, and Lifestyle Impact Fibroid Risk - OnlyMyHealth
Not Just Hormones: How Blood Pressure, Vitamin D, and Lifestyle Impact Fibroid Risk OnlyMyHealth
Published: July 15, 2025, 11:04 a.m.
UFE Doesn’t Remove Fibroids–Here’s What Women Aren’t Being Told - The Malaysian Reserve
UFE Doesn’t Remove Fibroids–Here’s What Women Aren’t Being Told The Malaysian Reserve
Published: June 26, 2025, 10:51 a.m.
UFE Doesn't Remove Fibroids--Here's What Women Aren't Being Told - StreetInsider
UFE Doesn't Remove Fibroids--Here's What Women Aren't Being Told StreetInsider
Published: June 25, 2025, 10:14 a.m.
UFE Doesn't Remove Fibroids—Here's What Women Aren't Being Told - Morningstar
UFE Doesn't Remove Fibroids—Here's What Women Aren't Being Told Morningstar
Published: June 25, 2025, 10 a.m.
The global burden of polycystic ovary syndrome, endometriosis, uterine fibroids, cervical cancer, uterine cancer, and ovarian cancer from 1990 to 2021 - BMC Public Health
The global burden of polycystic ovary syndrome, endometriosis, uterine fibroids, cervical cancer, uterine cancer, and ovarian cancer from 1990 to 2021 BMC Public Health
Published: May 14, 2025, 5:32 a.m.
TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids - BioSpace
TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids BioSpace
Published: May 7, 2025, 1:28 p.m.
TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids - The Manila Times
TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids The Manila Times
Published: May 7, 2025, 12:24 p.m.
TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids - PR Newswire
TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids PR Newswire
Published: May 7, 2025, noon
Link copied to clipboard!